Clinical Trial Update: Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3 [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial update reports on the safety and efficacy of lithium carbonate in patients with Spinocerebellar Ataxia Type 3 (Machado-Joseph disease) and not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Machado-joseph Disease
• Spinocerebellar Ataxia Type 3

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Spinocerebellar Ataxia Type 3, Machado Joseph Disease | Phase 2, Phase 3 | Status: COMPLETED